Elecated levels of IL-8 in fatal leptospirosis
Leptospirosis causes a wide range of clinical outcomes, including organ failure and death. Early treatment significantly increases the chances of cure. Interleukin-8 (IL-8) is a chemoattractant cytokine for neutrophil and is associated with multiple organ failure. Research has indicated IL-8 to be r...
保存先:
主要な著者: | , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Taylor and Francis
2020
|
オンライン・アクセス: | http://psasir.upm.edu.my/id/eprint/88764/1/CYTO.pdf http://psasir.upm.edu.my/id/eprint/88764/ https://www.tandfonline.com/doi/abs/10.1080/20477724.2020.1724356?journalCode=ypgh20 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
要約: | Leptospirosis causes a wide range of clinical outcomes, including organ failure and death. Early treatment significantly increases the chances of cure. Interleukin-8 (IL-8) is a chemoattractant cytokine for neutrophil and is associated with multiple organ failure. Research has indicated IL-8 to be raised in severe and fatal cases of leptospirosis, but its suitability as a prognostic biomarker has yet to be confirmed. This study aimed to evaluate the significance of IL-8 with the clinical outcomes of leptospirosis patients. Plasma IL-8 was measured in fifty-two samples from hospitalized patients and nineteen healthy controls. The comparisons were made between mild, severe-survived and fatal groups identified by clinical or laboratory findings. IL-8 was significantly higher in fatal (p = 0.01) compared to mild cases. IL-8 was also significantly higher in fatal (p = 0.02) when compared to survived cases of leptospirosis. IL-8 levels in the plasma of fatal leptospirosis cases were significantly elevated compared to survived cases and may serve as a potential prognostic biomarker in determining the possible outcome of leptospirosis patients. |
---|